Objective To explore the impact of nausea and vomiting management program based on shared decision-making on post-transarterial chemoembolization (TACE) nausea and vomiting in liver cancer patients.
Methods A shared decision-making aid was designed, and nausea and vomiting management program was developed. A total of 100 liver cancer patients who underwent TACE treatment in the Department of Interventional Radiology at Nantong Third People's Hospital from January to December 2023 were selected as study subjects. The control group (admitted from January to June 2023) received routine TACE perioperative nursing care, while the experimental group (admitted from July to December 2023) implemented the nausea and vomiting management program in addition to routine care. The incidence and severity of nausea and vomiting within 24 hours post-surgery, as well as the vomiting-related functional living index, quality of life, and self-efficacyin decision-making before and after the intervention were compared between the two groups.
Results Within 24 hours post-surgery, the incidence and severity of nausea and vomiting in the experimental group were lower than those in the control group, with statistically significant differences (P < 0.05). After the intervention, the total and dimensional scores of the Quality of Life in Liver Cancer (QOL-LC) scale and the vomiting-related functional living index in the experimental group were higher than those in the control group(P < 0.05). Additionally, the self-decision-making efficacy score in the experimental group was higher after the intervention than before intervention and higher than that in the control group (P < 0.05).
Conclusion The nausea and vomiting management program based on shared decision-making can effectively reduce the incidence and severity of post-TACE nausea and vomiting in liver cancer patients, and improve their quality of life, vomiting-related functional living index, and self-decision-making efficacy.
DownLoad: